Veeda Clinical Research refiles DRHP for IPO with Sebi

CX Partners backed Research Player, Veeda Clinical Research has refiled its Draft Red Herring Prospectus (DRHP) with capital markets regulator, Securities and Exchange Board of India (SEBI) to raise funds through Initial Public Offering (IPO).

The company had earlier filed its IPO papers with…